Business Context and Reporting Period
Company: Colgate-Palmolive Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2025
Business Overview: A global consumer products company operating in two primary segments: Oral, Personal and Home Care, and Pet Nutrition (Hill's). The company operates in over 200 countries, with approximately two-thirds of net sales generated outside the U.S. and 45% from emerging markets.
Key Financial Metrics
| Metric (in millions, except per share) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Sales | $5,131 | $5,033 | $15,152 | $15,156 |
| Gross Profit | $3,049 | $3,074 | $9,105 | $9,179 |
| Gross Margin | 59.4% | 61.1% | 60.1% | 60.6% |
| Operating Profit | $1,059 | $1,065 | $3,214 | $3,205 |
| Operating Margin | 20.6% | 21.2% | 21.2% | 21.1% |
| Net Income (Attributable to Colgate) | $735 | $737 | $2,169 | $2,150 |
| Diluted EPS | $0.91 | $0.90 | $2.67 | $2.61 |
| Operating Cash Flow (9M) | $2,745 | $2,838 | ||
| Total Debt | $8,419 | $7,949 (Dec 31, 2024) | ||
| Cash & Equivalents | $1,279 | $1,096 (Dec 31, 2024) |
Material Changes vs. Prior Period
- Sales Growth: Q3 2025 net sales increased 2.0% year-over-year, driven by net selling price increases (2.3%) and positive foreign exchange (1.2%), partially offset by volume declines (1.5%). Organic sales growth was 0.4%.
- Margin Compression: Gross profit margin decreased 170 basis points to 59.4% in Q3 2025. This was primarily due to significantly higher raw and packaging material costs (600 bps impact), partially offset by cost savings from funding-the-growth initiatives (290 bps) and higher pricing (90 bps).
- Segment Performance:
- Europe: Strongest performer with 7.6% sales growth and 16% operating profit growth.
- Latin America: Sales up 2.0%, but operating profit down 8% due to high material costs.
- North America: Sales down 0.4% and operating profit down 8%.
- Pet Nutrition: Sales up 1.4%, but organic sales declined 1.3% due to lower private label volume.
- Acquisition: Acquired Prime100 (Care TopCo Pty Ltd) in April 2025 for approximately $301 million to enter the fresh pet food category in Australia.
Guidance, Outlook, and Risks
- Strategic Initiatives: On July 31, 2025, the Board approved a new three-year "Strategic Growth and Productivity Program" estimated to result in cumulative pre-tax charges of $200 million to $300 million by 2028. No charges were recorded in Q3 2025.
- Outlook: Management expects continued challenging macroeconomic conditions, including inflation, high interest rates, and foreign currency volatility. Tariffs imposed by the U.S. and other countries are estimated to add approximately $75 million in incremental gross costs for 2025.
- Legal Contingencies:
- ERISA Litigation: Settled for $332 million (inclusive of fees) in Q3 2025. A charge of $65 million was recorded in Q1 2025; the settlement is subject to final court approval in January 2026.
- Talcum Powder: 402 cases pending as of September 30, 2025. Management believes it has strong legal grounds to contest these.
- Brazilian Tax Matters: Ongoing disputes regarding tax assessments totaling approximately $112 million (including penalties/interest). Management expects to prevail.
- Capital Allocation: Quarterly dividend increased to $0.52 per share. Share repurchases totaled $804 million in the first nine months of 2025.
Key Facts for Investor Verification
- Cost Inflation: Verify the sustainability of margin recovery given the 600 basis point headwind from raw material costs in Q3 2025.
- Volume Trends: Monitor organic volume declines (-1.5% in Q3) across key regions, particularly North America and Asia Pacific, amidst competitive pressure from private labels.
- Restructuring Impact: Track the execution and cash impact of the new $200-$300 million Strategic Growth and Productivity Program.
- Legal Resolution: Confirm the final court approval of the $332 million ERISA settlement and any potential additional costs.
- Tariff Exposure: Assess the actual impact of new U.S. tariffs on costs and the effectiveness of pricing actions to offset these increases.